Ravi Majeti

June 12, 2023

Dr. Majeti is the Director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine and is the Virginia and D.K. Ludwig Professor of Medicine in the Division of Hematology at Stanford Medical School. Dr. Majeti directs a research laboratory that focuses on the molecular characterization and therapeutic targeting of leukemia stem cells in human hematologic disorders, particularly AML, and has published over 120 peer-reviewed articles. Previously, he helped co-found Forty Seven Inc. with Dr. Weissman, and helped develop a humanized anti-CD47 antibody and initiated first-in-human clinical trials. He is a recipient of the Burroughs Wellcome Career Award for Medical Scientists, the New York Stem Cell Foundation Robertson Investigator Award, and the Leukemia and Lymphoma Society Scholar Award.